US Patent Issued to Bristol-Myers Squibb on March 17 for "Polymorphs of bis(fluoroalkyl)-1,4-benzodiazepinone compounds and uses thereof" (California, New Jersey Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,214, issued on March 17, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Polymorphs of bis(fluoroalkyl)-1,4-benzodiazepinone compounds and uses thereof" was invented by Marta Dabros (Foster City, Calif.), Joshua Engstrom (Spotswood, N.J.) and Daniel Richard Roberts (Robbinsville, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a crystalline form of (2R,3S)-N-((3S)-5-(3-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-2,3-bis(3,3,3-trifluoropropyl)succinimide, represented by the structure of Compound (1), wherein the crystalline form comprises N-2 crystalline form, IPA2-1 crystalline...